Cambridgeshire, United Kingdom

Nigel John Watkins

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Merck Patent Gmbh. Active years: 2010-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nigel John Watkins. Retrieved from https://idiyas.com/inventor/nigel-john-watkins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Nigel John Watkins

Introduction

Nigel John Watkins is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. With a total of 2 patents to his name, Watkins continues to push the boundaries of scientific innovation.

Latest Patents

Watkins' latest patents focus on the stabilization of Fc-interferon-beta fusion proteins. These patents disclose Fc-interferon-beta (Fc-IFN-β) fusion proteins and nucleic acid molecules encoding them. The Fc-IFN-β fusion proteins include variants of the interferon-beta (IFN-β) protein that are altered to achieve enhanced biological activity, prolonged circulating half-life, and greater solubility. Additionally, the patents outline methods for producing these fusion proteins and their applications in treating diseases and conditions alleviated by the administration of interferon-beta.

Career Highlights

Watkins is currently associated with Merck Patent GmbH, where he applies his expertise in biotechnology and patent development. His work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Some of his notable coworkers include Stephen D Gillies and Matthew Baker, who have collaborated with him on various projects within the company.

Conclusion

Nigel John Watkins exemplifies the spirit of innovation in biotechnology through his patents and contributions to the field. His work on Fc-interferon-beta fusion proteins holds promise for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…